Intrexon’s proprietary methanotroph bioconversion platform has the potential to transform the gas-to-liquids industry through use of optimized microbial cell lines to convert natural gas into higher carbon compounds such as isobutanol and farnesene under ambient temperatures and pressures.
By the end of 2018, Intrexon is guiding the market that it will have successfully commercialized a technology to convert methane, or the primary component of natural gas, into isobutanol, a liquid fuel with a density far closer to gasoline than ethanol. There has been substantial doubt raised, especially in The Motley Fool, regarding Intrexon’s […]
Intrexon’s proprietary methanotroph bioconversion platform has the potential to transform the gas-to-liquids industry through use of optimized microbial cell lines to convert natural gas into higher carbon compounds such as isobutanol and farnesene under ambient temperatures and pressures. This novel approach avoids costly, resource intensive thermochemical GTL conversion methods, and offers a biofuel that does […]
The indictment was handed down this week in The Motley Fool, which averred: Intrexon is…failing to learn the dangers of over-promising on manufacturing milestones. While investors have been told to expect the natural gas-to-fuels platform to be commercialized by 2018, real-world indicators essentially guarantee that won’t be the case — and hint that it won’t […]
In New York, Motley Fool has come out hitting hard at Intrexon and Amyris, convinced that the latter is on its way to a slow death and the former, that despite trying its hardest to not repeat the mistakes Amyris made, has instead made others that have basically sentenced it to death as well. Perhaps […]
In California, Intrexon Corporation has appointed Geno Germano to the new role of President of Intrexon effective June 1, 2016, reporting to Chairman and Chief Executive Officer Randal J. Kirk. As President, Mr. Germano will help lead Intrexon’s management team and commercialization efforts utilizing the Company’s technology platform for biologically-based solutions across a broad range […]
The High Priests of the Advanced Bioeconomy look upon the advocates of methane roughly the same way that Pope Leo X looked upon Martin Luther. It’s heresy, they say. With the exception of the happy but limited tonnes of biogas coming from digesters and landfill, it’s not renewable, goeth the rap against methane. It’s a […]
In California, Intrexon announced the pilot plant for its proprietary gas-to-liquids bioconversion platform is operational. The plant, which is located in South San Francisco, is dedicated to the production of isobutanol, a drop-in fuel with numerous advantages over other clean burning gasoline blendstocks. Intrexon’s methanotroph bioconversion platform is designed to generate high-value products from natural gas, […]
In California, Intrexon has formed Intrexon Energy Partners II (IEP II), a joint venture with a select group of unnamed “external investors”, to produce 1,4-butanediol (BDO), a key chemical intermediate with a global market value exceeding $5 billion that is used to manufacture spandex, polyurethane, plastics, as well as polyester. Through Intrexon’s advanced suite of […]
In California, Intrexon Energy Partners and Dominion Energy said they are exploring the potential for commercial-scale biological conversion of natural gas to isobutanol, using Intrexon’s proprietary methanotroph bioconversion platform, which can convert natural gas into higher carbon compounds such as isobutanol and farnesene under ambient temperatures and pressures. Background on the announcement: The shale basins […]
